BANCO MACRO SA-ADR(NYSE:BMA) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to BMA. BMA was compared to 398 industry peers in the Banks industry. BMA has a bad profitability rating. Also its financial health evaluation is rather negative. BMA shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past 5 years BMA has always been profitable.

In multiple years BMA reported negative operating cash flow during the last 5 years.

1.2 Ratios

With an excellent Return On Assets value of 4.49%, BMA belongs to the best of the industry, outperforming 99.75% of the companies in the same industry.

BMA's Return On Equity of 16.07% is amongst the best of the industry. BMA outperforms 94.47% of its industry peers.

		Industry Rank	Sector Rank
ROA	4.49%
ROE	16.07%
ROIC	N/A

ROA(3y)4.26%

ROA(5y)3.73%

ROE(3y)14.74%

ROE(5y)14.41%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BMA has a Profit Margin of 9.66%. This is amonst the worse of the industry: BMA underperforms 83.92% of its industry peers.

In the last couple of years the Profit Margin of BMA has declined.

BMA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	9.66%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-22.24%

PM growth 5Y-22.5%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for BMA remains at a similar level compared to 1 year ago.

Compared to 5 years ago, BMA has less shares outstanding

Compared to 1 year ago, BMA has an improved debt to assets ratio.

2.2 Solvency

BMA has a debt to FCF ratio of 5.90. This is a neutral value as BMA would need 5.90 years to pay back of all of its debts.

BMA has a Debt to FCF ratio of 5.90. This is in the lower half of the industry: BMA underperforms 72.11% of its industry peers.

A Debt/Equity ratio of 0.12 indicates that BMA is not too dependend on debt financing.

BMA's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. BMA outperforms 66.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	5.9
Altman-Z	N/A

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

		Industry Rank	Sector Rank
Current Ratio	N/A
Quick Ratio	N/A

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.84%, which is quite good.

BMA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 63.39% yearly.

Looking at the last year, BMA shows a very strong growth in Revenue. The Revenue has grown by 115.20%.

The Revenue has been growing by 110.09% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)8.84%

EPS 3Y79%

EPS 5Y63.39%

EPS Q2Q%-74.37%

Revenue 1Y (TTM)115.2%

Revenue growth 3Y130.21%

Revenue growth 5Y110.09%

Sales Q2Q%-12.02%

3.2 Future

BMA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 104.04% yearly.

BMA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.02% yearly.

EPS Next Y188.12%

EPS Next 2Y104.04%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-3.31%

Revenue Next 2Y4.02%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

BMA's earnings are expected to grow with 104.04% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y104.04%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BMA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BANCO MACRO SA-ADR

NYSE:BMA (4/30/2025, 8:04:00 PM)

After market: 88.5 -0.02 (-0.02%)

88.52

-1.94 (-2.14%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)02-26 2025-02-26/amc

Earnings (Next)05-20 2025-05-20

Inst Owners34.99%

Inst Owner Change-1.22%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap5.56B

Analysts81.67

Price TargetN/A

Short Float %1.45%

Short Ratio0.86

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP71.76%

Div Incr Years2

Div Non Decr Years2

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)16.4%

Min Revenue beat(2)0.49%

Max Revenue beat(2)32.32%

Revenue beat(4)4

Avg Revenue beat(4)58.01%

Min Revenue beat(4)0.49%

Max Revenue beat(4)128.84%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-0.33%

EPS NY rev (1m)-18.13%

EPS NY rev (3m)26.92%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-4.51%

Revenue NY rev (3m)-2.83%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)N/A

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpSN/A

BVpSN/A

TBVpSN/A

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	4.49%
ROE	16.07%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	9.66%
GM	N/A
FCFM	1.25%

ROA(3y)4.26%

ROA(5y)3.73%

ROE(3y)14.74%

ROE(5y)14.41%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-22.24%

PM growth 5Y-22.5%

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0.12
Debt/FCF	5.9
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	1.85%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	12.9%
Current Ratio	N/A
Quick Ratio	N/A
Altman-Z	N/A

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)3.11%

Cap/Sales(5y)3.07%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)8.84%

EPS 3Y79%

EPS 5Y63.39%

EPS Q2Q%-74.37%

EPS Next Y188.12%

EPS Next 2Y104.04%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)115.2%

Revenue growth 3Y130.21%

Revenue growth 5Y110.09%

Sales Q2Q%-12.02%

Revenue Next Year-3.31%

Revenue Next 2Y4.02%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y104.2%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y110.74%

OCF growth 3YN/A

OCF growth 5YN/A

BANCO MACRO SA-ADR (BMA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens